Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 110885290A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110885290A discloses a novel route for 3-fluoro-2-methyl-4-trifluoromethylaniline hydrochloride via Buchwald-Hartwig amination, ensuring high purity and scalable production for pharmaceutical intermediates.